Wijsenbeek MS - Search Results

1

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns.

Kreuter M, Wijsenbeek MS, Vasakova M, Spagnolo P, Kolb M, Costabel U, Weycker D, Kirchgaessler KU, Maher TM. Kreuter M, et al. Among authors: wijsenbeek ms. Eur Respir J. 2016 Nov;48(5):1524-1526. doi: 10.1183/13993003.01482-2016. Eur Respir J. 2016. PMID: 27799399 Free article. No abstract available.

2

Serum biomarkers in idiopathic pulmonary fibrosis.

van den Blink B, Wijsenbeek MS, Hoogsteden HC. van den Blink B, et al. Among authors: wijsenbeek ms. Pulm Pharmacol Ther. 2010 Dec;23(6):515-20. doi: 10.1016/j.pupt.2010.08.001. Epub 2010 Aug 12. Pulm Pharmacol Ther. 2010. PMID: 20708704 Review.

3

Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis.

Judson MA, Baughman RP, Costabel U, Drent M, Gibson KF, Raghu G, Shigemitsu H, Barney JB, Culver DA, Hamzeh NY, Wijsenbeek MS, Albera C, Huizar I, Agarwal P, Brodmerkel C, Watt R, Barnathan ES. Judson MA, et al. Among authors: wijsenbeek ms. Eur Respir J. 2014 Nov;44(5):1296-307. doi: 10.1183/09031936.00000914. Epub 2014 Jul 17. Eur Respir J. 2014. PMID: 25034562 Free article. Clinical Trial.

4

[Idiopathic pulmonary fibrosis: new insights].

Kraan JW, van den Blink B, van den Toorn LM, Bresser P, van Beek FT, Grutters JC, Wijsenbeek MS. Kraan JW, et al. Among authors: wijsenbeek ms. Ned Tijdschr Geneeskd. 2015;159:A8148. Ned Tijdschr Geneeskd. 2015. PMID: 25654681 Review. Dutch.

5

Challenges in the classification of fibrotic ILD.

Bendstrup E, Maher TM, Manali ED, Wijsenbeek M. Bendstrup E, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 3;32 Suppl 1:4-9. Sarcoidosis Vasc Diffuse Lung Dis. 2015. PMID: 26237436 Review.

6

Cultural Differences in Palliative Care in Patients With Idiopathic Pulmonary Fibrosis.

Wijsenbeek M, Bendstrup E, Ross J, Wells A. Wijsenbeek M, et al. Chest. 2015 Aug;148(2):e56. doi: 10.1378/chest.15-0705. Chest. 2015. PMID: 26238839 No abstract available.

7

European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers.

Bonella F, Wijsenbeek M, Molina-Molina M, Duck A, Mele R, Geissler K, Wuyts W. Bonella F, et al. Eur Respir J. 2016 Feb;47(2):597-606. doi: 10.1183/13993003.01204-2015. Epub 2015 Nov 19. Eur Respir J. 2016. PMID: 26585424 Free article.

8

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives.

Kreuter M, Bonella F, Wijsenbeek M, Maher TM, Spagnolo P. Kreuter M, et al. Biomed Res Int. 2015;2015:329481. doi: 10.1155/2015/329481. Epub 2015 Dec 8. Biomed Res Int. 2015. PMID: 26779535 Free PMC article. Review.

9

Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy.

van den Blink B, Dillingh MR, Ginns LC, Morrison LD, Moerland M, Wijsenbeek M, Trehu EG, Bartholmai BJ, Burggraaf J. van den Blink B, et al. Eur Respir J. 2016 Mar;47(3):889-97. doi: 10.1183/13993003.00850-2015. Epub 2016 Feb 11. Eur Respir J. 2016. PMID: 26869678 Free article. Clinical Trial.

10

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.

Kreuter M, Wijsenbeek MS, Vasakova M, Spagnolo P, Kolb M, Costabel U, Weycker D, Kirchgaessler KU, Maher TM. Kreuter M, et al. Among authors: wijsenbeek ms. Eur Respir J. 2016 Jun;47(6):1776-84. doi: 10.1183/13993003.02087-2015. Epub 2016 Apr 21. Eur Respir J. 2016. PMID: 27103382 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters